Inclusion Criteria:  Patient with a history of paroxysmal (intermittent), persistent or long-standing persistent atrial fibrillation and who have undergone or will undergo ablation treatment Patient >= 18 years of age  Exclusion Criteria:  Subject is enrolled in a concurrent study that has not been approved for concurrent enrollment by the global study manager Subject with exclusion criteria required by FDA or local governance